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How do CD1 molecules load lipid antigens? In this issue of Immunity, Relloso et al. (2008) uncover how
lysosomal pH targets amino acids in CD1b, causing it to open and attain a conformation more receptive to
lipid antigens.X-ray crystallographic studies have re-
vealed the structures of several com-
plexes of lipid antigens bound to different
CD1 isoforms (Zajonc and Kronenberg,
2007). Although these structures show
how the aliphatic chains of diverse anti-
gens fit into pockets in the grooves of
CD1 proteins, they reveal a fundamental
topologic problem. Unlike MHC class I
and class II molecules, the grooves of
CD1 molecules are not open along their
length. The lipid tails are buried, and a por-
tal over what is usually called the F0 pocket,
toward the carboxyl terminal of the a heli-
ces, permits the emergence of the hydro-
philic head groups of CD1-bound antigens
(Zajonc and Kronenberg, 2007). Antigens
with long hydrophobic chains therefore
somehow must traverse a relatively small
portal in the roof of the CD1 molecules to
enter the antigen-binding groove. Now,
a comprehensive report in this issue (Re-
lloso et al., 2008) has combined modeling
with immunochemical methods to provide
a better understanding of the mechanism
of insertion of lipids into the CD1 groove.
CD1 proteins are a family of antigen-pre-
senting molecules found in most verte-
brates. Their hydrophobic grooves present
lipid antigens, which are mostly glyco-
lipids. The CD1 gene family contains evo-
lutionarily divergent members that are
not uniformly represented in differentspecies (Dascher, 2007). For example, in
humans there are four CD1 isotypes—
CD1a, CD1b, CD1c, and CD1d—but only
a CD1d ortholog in mice. CD1-reactive
T cells have a unique biology. Natural killer
T (NK T) cells with an invariant TCRa chain
recognize CD1d. These NKT cells share
features with innate immune cells, and, at
least in mice, they are critical for the regu-
lation of many immune responses (Bende-
lac et al., 2007). The human CD1a, CD1b,
and CD1c proteins, by contrast, present
lipids from mycobacterial species to T lym-
phocytes with diverse antigen receptors.
The properties of these mycobacterial-re-
active T cells suggest that they constitute
part of the adaptive immune response for
host defense (Barral and Brenner, 2007).
Working with lipids presents special
challenges, as they are famously sticky,
and, moreover, unlike peptides they mostly
exist in organized macromolecular struc-
tures, such as micelles and bilayers. De-
spite this, it has beenpossible tomakesub-
stantial progress in understanding how
CD1 proteins get loaded with lipid-contain-
ing antigens, in part by following the route
of CD1 molecules in antigen-presenting
cells (APCs). As outlined in Figure 1, CD1
polypeptides assemble with autologous
phospholipids, such as phosphatidylcho-
line, and spacer lipids in the endoplasmic
reticulum (Barral and Brenner, 2007; DeImmuLibero and Mori, 2008; Garcia-Alles et al.,
2006). After transport to the cell surface,
either directly from the Golgi network or
through an endosomal intermediate, CD1
isoforms subsequently are internalized,
and they recycle through endosomal com-
partments, where self-phospholipids are
exchanged for various self- and foreign
antigens. Interestingly, different CD1 mole-
cules are adapted to survey different endo-
somal compartments. For example, CD1a
recycles through early endosomes, but hu-
man CD1b and mouse CD1d make their
way deep into lysosomal compartments
to acquire antigens (Barral and Brenner,
2007; De Libero and Mori, 2008).
Sphingolipid activator proteins, includ-
ing the four saposins and the GM2 activa-
tor protein, as well as the Niemann-Pick
type C2 protein, are important for lipid
antigen exchange in lysosomes, thereby
augmenting CD1-mediated antigen pre-
sentation (Barral and Brenner, 2007; De
Libero and Mori, 2008). Some of these
proteins perturb membranes, thereby
making glycolipids more susceptible to
interaction with other proteins, whereas
others may directly facilitate lipid ex-
change with membranes. Not only do
they colocalize in late endosomes and ly-
sosomes with CD1 molecules, but several
sphingolipid activator proteins also bind
to CD1. Despite these recent advances,nity 28, June 2008 ª2008 Elsevier Inc. 727
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tigen exchange process remain
largely unknown.
Here, Relloso et al. (2008) fo-
cused on human CD1b and its
presentation of the mycobacte-
rial cell wall antigen glucose
monomycolate (GMM) to
a cloned T cell. CD1b is distin-
guished by its ability to bind
and present lipids with longer
hydrophobic chains, and by its
preferential trafficking to lyso-
somes. The GMM antigen has
a single glucose, and forms
that contain either 32 (C32
GMM) or 80 (C80 GMM) carbons
were used. Previous work had
shown that acidic pH caused
conformational changes in
CD1b that enhanced its ability
to bind hydrophobic com-
pounds (Ernst et al., 1998; Im
et al., 2004), including GMM
with longer hydrophobic tails
(Cheng et al., 2006). This sug-
gested to Relloso et al. (2008)
that acidic amino acids could
be important for lipid antigen
loading, as glutamic (E) and as-
partic (D) acids will lose nega-
tive charge as a result of proton-
ation as the pH decreases. The
authors propose that the partial
loss of negative charge in the
acidic lysosomal environment
might unfurl the CD1b groove, allowing it
to more easily bind lipids, especially those
with longer alkyl chains (Figure 1). A corol-
lary is that ionic interactions at the neutral
pH of the cell surface might tether CD1b,
making it less accessible to bulky lipid an-
tigens. The authors therefore offer the ap-
pealing hypothesis that ‘‘ionic tethers’’ act
as ‘‘molecular switches’’ that regulate the
conformation of CD1b as it responds
to pH changes during endolysosomal
trafficking.
Relloso et al. (2008) carried out experi-
ments to address the more specific ques-
tions of which acidic amino acids are
titrated to permit increased lipid binding
and how they help to lock the CD1b mol-
ecule in its slow-on and slow-off state at
neutral pH. Molecular dynamics simula-
tions were used to identify regions of the
CD1b molecule that have a more flexible
conformation. One in the lateral wall of
a pocket in the CD1b groove and another
in the roof near the portal at the top of the
protein were judged to most likely have
a direct involvement in antigen loading.
This information helped in the choice of
acidic amino acids to mutate, and five po-
sitions were selected. Of the five, muta-
tions that removed negative charges at
D60 or E62 led to increased antigen pre-
sentation, a gain of function suggestive
of increased lipid accessibility. The exist-
ing structures of CD1b show that amino
acids at these positions stabilize the
CD1b structure in a more closed confor-
mation by linking the a1 helix to a2, or
by stabilizing a flexible loop at the end of
the a1 helix.
Several experiments demonstrated in-
creased lipid accessibility in the absence
of the anionic tethers. First, soluble ver-
sions of the mutant CD1b proteins inter-
acted better with a hydrophobic fluores-
cent probe, showing greater accessibility
of the antigen-binding groove. Second,
in short-term presentation as-
says, in which antigen loading
of CD1b occurs predominantly
on the cell surface, the tether
mutations enhanced the pre-
sentation of C80 GMM. The
opposite effect on C32 GMM
presentation was attributed to
an increased off rate from bind-
ing the more open mutant
CD1b molecules. This conclu-
sion was supported by the re-
sults from a pulse-chase assay,
in which APC pulsed briefly
with antigen were chased in an-
tigen-free media before stimu-
lation of T cells. With APC ex-
pressing wild-type CD1b, the
ability to respond to C32 GMM
decayed more quickly during
the chase than the ability to re-
spond to C80 GMM, consistent
with earlier data indicating that
more hydrophobic antigens
have stable binding to CD1b.
Furthermore, when presented
by CD1b proteins with tether
mutations, the decay in the
ability to present either antigen
was accelerated.
When antigen loading oc-
curred at low pH, changes in
antigen binding and presenta-
tion by wild-type CD1b were
similar to those induced by the
tether mutations, including in-
creased binding of fluorescent probes
and increased GMM loading at the cell
surface. In fact, the C80 GMM could not
be loaded on the cell surface unless the
pH were 5.5 or less during the loading re-
action, although C32 GMM could be
loaded to some extent at neutral pH. Fur-
thermore, binding of either GMM antigen
was less stable at low pH. The combined
effects of acid pH and tether mutations
were less than additive, however, sug-
gesting that low pH and disruption of the
tethers by mutation were affecting pre-
dominantly the same pathway.
Although the data are convincing, one
might question what fraction of the CD1b
molecules were protonated at the key
amino acids. The pKa is the pH at which
half of an acid is protonated, and for free
D and E amino acids, the pKa values are
3.9 and 4.1, respectively. The chemical
formula predicts at pH 5.0, typical of late
endosomes and a value that substantially
Figure 1. Depiction of CD1b Trafficking in APCs and the
pH-Dependent Conformational Change
(Top) Intracellular CD1b trafficking route. After exiting the trans-Golgi net-
work, CD1b molecules arrive at the cell surface and then recycle through
endosomal compartments of decreasing pH before returning to the cell
surface. EE, early endosomes; LE, late endosomes; TGN, trans-Golgi net-
work; and ER, endoplasmic reticulum.
(Bottom) Schematic of pH-dependent conformational change in CD1b. At
the acidic pH of late endosomes, protonation of acidic amino acids leads
to the loss of negative charge. The result is the neutralization of ionic
tethers, which allows the CD1b groove to open and bind lipid antigens
with longer alkyl chains.728 Immunity 28, June 2008 ª2008 Elsevier Inc.
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face, less than 10% of the CD1b mole-
cules would be protonated at position
60. With a similar percentage protonated
at position 62, very few CD1b molecules
would have both anionic tethers neutral-
ized. However, because the surrounding
amino acids in a folded protein can sub-
stantially influence ionization, the authors
asserted that estimates based on the
pKa of free amino acids are not accurate.
In fact, a predictive model that takes pro-
tein context into account suggested that
more than a few percent of the CD1b mol-
ecules would be protonated at the pH of
late endosomes and lysosomes.
Although the results provided by Relloso
et al. (2008) give great insight into the dy-
namics of CD1b lipid antigen loading, an
unresolved issue is how the functions of
the sphingolipid activator proteins in lyso-
somes, such as the saposins, interplayBridging Toll-like-
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adaptive immune receptor functions
receptor 9 (TLR9)-containing endos
Pattern-recognition receptors (PRRs) act
as sentinels of the immune system, alert-
ing both the innate and the adaptive im-
mune system to the presence of microbial
pathogens (Medzhitov, 2007). Invariant
regions within microbes, such as cell-
wall components of bacteria and fungi,
trigger signaling through PRR and induce
immune activation. Toll-like receptors
(TLRs) are a well-characterized subset of
PRR and play a key role in the detection
of microbes, as in the case of TLR4
triggering by lipopolysaccharide (LPS),
a Gram-negative bacterial-cell-wall com-
ponent. Perhaps one of the more intrigu-
ing problems inherent to TLR specificitywith the direct effects of pH on CD1b con-
formation. For example, do these acces-
sory proteins interact preferentially with
the protonated form of CD1b, or do they
stabilize the more open conformation?
Also, do anionic switches influence the be-
havior of the other CD1 isoforms? Further
studies clearly are needed to determine if
the current findings can be generalized to
lipid loading of other CD1 isoforms.
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